DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glipizide (Glipizide) - Injection Site Haematoma - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Injection Site Haematoma (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Glipizide where reactions include injection site haematoma. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-05-24

Patient: 67 year old male

Reactions: Wrong Technique in Drug Usage Process, Injection Site Haematoma, Blood Glucose Fluctuation, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Metfformin Hydrochloride
    Dosage: 2000 mg (1000 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Lantus
    Dosage: (15 iu, 1 d), subcutaneous; (10 iu), subcutaneous; (5 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01

Lantus
    Dosage: (15 iu, 1 d), subcutaneous; (10 iu), subcutaneous; (5 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: (15 iu, 1 d), subcutaneous; (10 iu), subcutaneous; (5 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Glipizide
    Dosage: 20 mg (10 mg, 2 in 1 d)
    Indication: Diabetes Mellitus



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-05-18

Patient: 67 year old male

Reactions: Injection Site Haematoma, Diabetes Mellitus Inadequate Control, Blood Glucose Increased

Drug(s) suspected as cause:
Lantus
    Dosage: 10 iu, unk
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 5 iu, daily
    Start date: 2011-11-01

Glipizide
    Dosage: 10 mg, 2x/day
    Indication: Diabetes Mellitus

Metformin HCL
    Dosage: 1000 mg, 2x/day

Lantus
    Dosage: 15 iu, 1x/day (parenteral injection,solution 100 international unit(s) millilitre (100iu/ml)
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-04-24

Patient: 67 year old male

Reactions: Wrong Technique in Drug Usage Process, Injection Site Haematoma, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Glipizide
    Dosage: 20 mg (10 mg, 2 in 1 d),(10 iu), (5 iu, 1 d)
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Glipizide
    Dosage: 20 mg (10 mg, 2 in 1 d),(10 iu), (5 iu, 1 d)
    Indication: Diabetes Mellitus
    Start date: 2011-11-01

Metformin HCL
    Dosage: 2000 mg (1000 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Lantus
    Dosage: (15 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-04-18

Patient: 67 year old male

Reactions: Injection Site Haematoma, Diabetes Mellitus Inadequate Control, Blood Glucose Increased

Drug(s) suspected as cause:
Lantus
    Dosage: 10 iu, unk
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 5 iu, daily
    Start date: 2011-11-01

Glipizide
    Dosage: 10 mg, 2x/day
    Indication: Diabetes Mellitus

Lantus
    Dosage: 15 iu, 1x/day (parenteral injection,solution 100 international unit(s) millilitre (100iu/ml)
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Metformin HCL
    Dosage: 1000 mg, 2x/day



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-03-14

Patient: 67 year old male

Reactions: Injection Site Haematoma, Drug Administration Error, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Glipizide
    Dosage: (2 in 1 d)
    Indication: Diabetes Mellitus

Lantus
    Dosage: (15 iu, 1 d), subcutaneous, (10 iu), subcutaneous, (5 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: (15 iu, 1 d), subcutaneous, (10 iu), subcutaneous, (5 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: (15 iu, 1 d), subcutaneous, (10 iu), subcutaneous, (5 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01

Metformin HCL
    Dosage: (2 in 1 d)
    Indication: Product Used FOR Unknown Indication



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 67 year old male

Reactions: Injection Site Haematoma, Diabetes Mellitus Inadequate Control, Blood Glucose Increased

Drug(s) suspected as cause:
Lantus
    Dosage: 15 iu, 1x/day (parenteral injection,solution 100 international unit(s) millilitre (100iu/ml)
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 10 iu, unk
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 5 iu, daily
    Start date: 2011-11-01

Glipizide
    Dosage: unk, 2x/day
    Indication: Diabetes Mellitus

Metformin HCL
    Dosage: unk, 2x/day



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-02-14

Patient: 67 year old male

Reactions: Blood Glucose Decreased, Injection Site Haematoma, Drug Administration Error, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Glipizide
    Dosage: (2 in 1 d),
    Indication: Diabetes Mellitus

Metformin HCL
    Dosage: (2 in 1 d),
    Indication: Product Used FOR Unknown Indication

Lantus
    Dosage: (15 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-02-09

Patient: 67 year old male

Reactions: Injection Site Haematoma, Diabetes Mellitus Inadequate Control, Blood Glucose Increased

Drug(s) suspected as cause:
Lantus
    Dosage: 10 iu, unk
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 15 iu, 1x/day (parenteral injection,solution 100 international unit(s) millilitre (100iu/ml)
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 5 iu, daily
    Start date: 2011-11-01

Metformin HCL
    Dosage: unk, 2x/day

Glipizide
    Dosage: unk, 2x/day
    Indication: Diabetes Mellitus



Possible Glipizide side effects in 67 year old male

Reported by a individual with unspecified qualification from United States on 2012-02-08

Patient: 67 year old male

Reactions: Wrong Technique in Drug Usage Process, Injection Site Haematoma, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Glipizide
    Dosage: (2 in 1 d)
    Indication: Diabetes Mellitus

Metformin HCL
    Dosage: (2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Lantus
    Dosage: (15 iu, 1 d), subcutaneous
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01



Possible Glipizide side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-02-03

Patient: 67 year old male

Reactions: Injection Site Haematoma, Diabetes Mellitus Inadequate Control, Blood Glucose Increased

Drug(s) suspected as cause:
Metformin HCL
    Dosage: unk, 2x/day

Glipizide
    Dosage: unk, 2x/day
    Indication: Diabetes Mellitus

Lantus
    Dosage: 15 iu, daily
    Indication: Diabetes Mellitus
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 10 iu, unk
    Start date: 2011-11-01
    End date: 2011-11-01

Lantus
    Dosage: 5 iu, daily
    Start date: 2011-11-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017